The novel interactors CACNA1I and CACNA1G targeted by nervous system drugs are calcium channels that are known to be associated with Alzheimer’s disease and schizophrenia, respectively93,94. The gene discussed is CACNA1G; the disease is early-onset autosomal dominant Alzheimer disease.